Buy Cardura (Doxazosin) Online — Pfizer Alpha-1 Adrenergic Receptor Blocker for Hypertension & Benign Prostatic Hyperplasia (BPH) Dual Treatment

🕓 The Doxazosin Story — From First-Line to Second-Line

🎯 Where Doxazosin Genuinely Belongs Today

⚖️ DOXAZOSIN — FIVE PRACTICAL CONCERNS

Each concern is covered in detail in sections 9, 11, 12, 13, and 19.

🧭 Reader Navigation — Jump to What Matters for You

• First prescription and bedtime dosing rule: sections 8, 9, 11
• BPH-specific use and titration: sections 5, 7, 15
• ALLHAT trial and hypertension role: section 6
• Falls risk and postural hypotension: sections 12, 22
• Cataract surgery (IFIS): section 13
• Metabolic profile in diabetes/dyslipidemia: section 18
• Rare priapism warning: section 19
• Switching to another alpha-1 blocker: section 26

💊 Doxazosin Pharmacokinetics at a Glance

🕑 Why the Long Half-Life Matters Practically

The 22-hour half-life produces two practical consequences:

• Steady BP effect across 24 hours with once-daily dosing
• Slow onset of first-dose effect — peak hypotensive effect at 2-6 hours, which is why bedtime dosing places any symptomatic dip during sleep (section 9)

The GITS Formulation Explained

Cardura XL uses Gastrointestinal Therapeutic System technology — an osmotic pump within the tablet shell that delivers drug at a controlled rate over 24 hours. This produces a smoother pharmacokinetic profile than the IR formulation and reduces first-dose peak effects. The empty tablet shell may appear intact in the stool; this is expected and does not indicate drug loss.

🧬 What Alpha-1 Blockade Does at Each Target Tissue

Why Selectivity for Alpha-1 Matters

Alpha-2 blockade would have unwanted effects: alpha-2 receptors on presynaptic neurons normally provide feedback inhibition of noradrenaline release. Blocking alpha-2 would cause massive noradrenaline release and paradoxical tachycardia. Older non-selective agents like phentolamine have this problem; doxazosin (selective for alpha-1) does not.

Two Practical Mechanistic Points

First, the venodilation is what makes the postural hypotension so pronounced on alpha-1 blockers — the drug reduces both arterial resistance and venous return. Second, the prostatic effect is what makes doxazosin useful for BPH — the same mechanism that lowers BP relaxes the prostate stroma and improves urine flow.

🔬 The Three Alpha-1 Receptor Subtypes

🗺️ Where Doxazosin Sits Among Alpha-1 Blockers

The Choice of Which Alpha-1 Blocker

Doxazosin is chosen when both hypertension and BPH are present, when the dual effect is desirable. Tamsulosin or silodosin is chosen when BPH is the sole target and the patient is normotensive or already well-controlled on other antihypertensives (BP-lowering effect of doxazosin would be superfluous or unwanted).

Where Doxazosin Sits in Hypertension Guidelines Post-ALLHAT

Modern guidelines position doxazosin as second- or third-line antihypertensive, not first-line. First-line options are ACE inhibitors, ARBs, calcium channel blockers, and thiazides. Doxazosin earns its place when hypertension coexists with BPH (one drug covers both) or as an add-on in resistant hypertension after three or four other classes have been tried.

📉 ALLHAT Doxazosin Arm at a Glance

⛔ WHY THE DOXAZOSIN ARM WAS STOPPED EARLY

Interim analysis in early 2000 showed doubled heart failure hospitalisation risk on doxazosin versus chlorthalidone. The Data Safety Monitoring Board judged that continuing patients in the doxazosin arm was not ethical given this signal, and the arm was terminated. Patients were transitioned to other antihypertensives.

Why the Heart Failure Signal Emerged

Two mechanisms are proposed:

• Neurohormonal activation — alpha-1 blockade produces reflex sympathetic activation that in vulnerable patients (elderly, borderline LV function) may unmask heart failure
• Absence of protective RAAS blockade — chlorthalidone, ACE-I, and ARB provide direct or indirect RAAS effects with prognostic benefit; alpha-1 blockade does not

Dr Casillas-Trevino on ALLHAT and modern practice

"ALLHAT was one of the trials that fundamentally changed how we prescribe. Before ALLHAT, alpha-1 blockers were among our first-line antihypertensives. After ALLHAT, they moved to second- and third-line, and in modern guidelines the position is very clear: doxazosin is not the first drug we reach for in uncomplicated hypertension. What ALLHAT did not do was disqualify doxazosin entirely — the drug retains legitimate roles in resistant hypertension as add-on and in the specific patient with concurrent BPH. But the days of doxazosin as first-line monotherapy for hypertension are over."

Enrique M. Casillas-Trevino, MD, PhD — Fundacion Favaloro, Instituto de Cardiologia y Cirugia Cardiovascular, Buenos Aires

👨‍⚕️ How Doxazosin Improves BPH Symptoms

The prostate has two functional components contributing to BPH symptoms:

• Static component — volume of the adenoma pressing on the urethra (addressed by 5-alpha reductase inhibitors like finasteride)
• Dynamic component — smooth muscle tone at the bladder neck and prostate stroma (addressed by alpha-1 blockade including doxazosin)

Doxazosin acts on the dynamic component. Symptomatic improvement is often noticeable within days to weeks — faster than the months required for 5-alpha reductase inhibitors to reduce prostate volume.

BPH Symptoms Improved by Doxazosin

Dr Anagbogu-Nwosu on doxazosin in BPH practice

"In urological practice we still use doxazosin regularly for symptomatic BPH, particularly when the patient also has hypertension — the dual benefit is a real advantage. For BPH-only cases in normotensive men, uroselective alpha-1 blockers (tamsulosin, silodosin) are often preferred because they produce fewer cardiovascular side effects. The decision depends on the patient's specific comorbidities. In West African urological practice, the availability and cost of doxazosin generics make it a very reasonable first-line pharmacological choice for BPH."

Chidozie E. Anagbogu-Nwosu, MBBS, FMCS (Urology), FWACS — Department of Urology, University College Hospital Ibadan

📆 Titration for Essential Hypertension (IR)

1. Start: 1 mg at bedtime (mandatory for first dose — see section 9)
2. Days 1-3: continue 1 mg at bedtime; note tolerability
3. Weeks 1-2: if tolerated, may switch to morning dosing
4. Titrate up if BP not at target: to 2 mg, then 4, 8, 16 mg once daily
5. Maximum: 16 mg per day; usual maintenance 4-8 mg
6. Combine if not at target: ACE-I/ARB, CCB, thiazide (avoid stacking a second alpha-1 blocker)

👨‍⚕️ Titration for BPH (IR)

1. Start: 1 mg at bedtime (still mandatory)
2. Days 7-14: titrate to 2 mg once daily
3. Weeks 2-4: titrate to 4 mg once daily — typical BPH maintenance
4. Weeks 4+: up to 8 mg once daily if symptoms persist
5. Maximum: 8 mg per day for BPH

GITS (Cardura XL) Titration — The Simpler Route

GITS is designed to reduce the first-dose peak effect. Starting dose is 4 mg once daily (not 1 mg as with IR), and the switch to GITS can be done from any IR maintenance dose. This is why GITS is often the preferred initial choice for chronic ambulatory prescribing, particularly in the elderly.

🚩 DO NOT CRUSH OR CHEW GITS TABLETS

Cardura XL uses an osmotic tablet shell that must remain intact for the controlled-release mechanism to work. Crushing destroys this and delivers a full day's dose over 1-2 hours, producing severe hypotension and syncope. If the patient has swallowing difficulty, IR tablets (which can be split at the scored line) are the alternative.

🚩 THE FIRST-DOSE RULE — MANDATORY

The first dose of doxazosin must be taken at bedtime to place the peak hypotensive effect (2-6 hours after dose) during sleep. Daytime first dose has produced severe symptomatic hypotension, syncope, falls with injury, and rarely serious cardiovascular events.

This rule applies to any restart after gap greater than 7 days as well — the receptor sensitisation resumes and first-dose risk returns.

▶️ First-Dose Safety Measures

⚠️ Patients at Highest First-Dose Risk

• Elderly patients (slower baroreceptor reflexes, more common polypharmacy)
• Patients on diuretics (volume depletion amplifies effect)
• Patients on other antihypertensives (additive effect)
• Patients on PDE5 inhibitors (sildenafil, tadalafil for ED)
• Patients with recent volume loss (gastroenteritis, aggressive diuresis)
• Warm ambient temperature (heat produces some vasodilation)

The PDE5 Inhibitor Combination — A Specific Consideration

Many older men on doxazosin for BPH also use PDE5 inhibitors (sildenafil, tadalafil) for erectile dysfunction. Both drugs lower blood pressure. Rules: on doxazosin, PDE5 inhibitor started at lowest dose (25 mg sildenafil, 2.5 mg tadalafil); separate doxazosin and PDE5 doses by at least 4 hours; watch for symptomatic hypotension particularly after first PDE5 use.

🕑 Time-Course of the First-Dose Effect

Why Bedtime Timing Works

Taking the first dose at bedtime places the 2-6 hour peak effect during the middle of the night while the patient is horizontal. Any BP fall does not produce syncope because the patient is not standing. By the time the patient wakes up and stands, the peak has passed and only the steady maintenance effect remains.

Tolerance Development

The first-dose phenomenon diminishes markedly after the first 3-7 doses. This is why:

• The first 3 nights are the specific high-risk window
• Dose escalations should also be taken at bedtime
• A gap of 7 days or more resets the sensitivity — restart at 1 mg bedtime
• Missed doses within a week do not reset sensitivity

🚩 IF SYNCOPE OCCURS AFTER FIRST DOSE

• Lie flat; elevate legs; do not attempt to stand
• Chest pain, difficulty breathing, or prolonged unconsciousness: emergency care
• If brief and self-resolving: contact prescriber next day for review; do not take second dose without medical input
• Restart requires supervised approach and possibly a lower dose or switch to GITS

💔 What Counts as Postural Hypotension

Practical Management of Postural Symptoms

Dr Bergman-Lindstrom on falls risk in elderly doxazosin users

"In our falls prevention clinic in Gothenburg, alpha-1 blockers are one of the medication classes we specifically screen for in every elderly patient with recurrent falls. Doxazosin is not disqualified — it may be essential for BPH or resistant hypertension — but the postural drop must be quantified at each visit. A standing systolic drop of 30 mmHg with symptoms is a red flag that warrants either dose reduction or switch to a uroselective alpha-1 blocker if BPH is the sole indication."

Kajsa E. Bergman-Lindstrom, MD, PhD — Department of Geriatric Medicine and Falls Prevention Unit, Sahlgrenska University Hospital, University of Gothenburg

👁️ What Happens in IFIS

During cataract surgery the iris is normally dilated with mydriatic drops and maintains that dilation throughout the procedure. In IFIS, three characteristic features appear:

1. Progressive intraoperative miosis (pupil constriction despite dilating drops)
2. Billowing of the flaccid iris tissue in response to intraocular fluid currents
3. Iris prolapse toward incision sites

These features make surgery more difficult and raise the risk of complications including iris trauma, posterior capsule rupture, and prolonged operating time.

🚩 STOPPING DOXAZOSIN BEFORE SURGERY DOES NOT PREVENT IFIS

IFIS has been observed months and even years after alpha-1 blocker discontinuation. The drug appears to produce a semi-persistent effect on iris dilator muscle that is not fully reversed by simply stopping the medication. Any patient who has ever taken doxazosin (or another alpha-1 blocker) should have this history conveyed to the cataract surgeon.

Practical Management of IFIS Risk

• Disclose alpha-1 blocker history to any ophthalmologist evaluating cataract
• Do not stop doxazosin routinely before cataract surgery unless the surgeon specifically requests it — stopping does not prevent IFIS and may destabilise BP or BPH management
• Cataract surgeon prepares with pharmacological (intracameral phenylephrine, atropine) or mechanical (iris hooks, Malyugin rings) measures
• Surgery is performed by an experienced surgeon aware of IFIS — do not accept junior operator for known IFIS-risk patient

Dr Bouchard-Tremblay on IFIS in cataract practice

"IFIS was first described in association with tamsulosin, but we now recognise it with the whole alpha-1 blocker class including doxazosin. The critical points for our cataract patients are: first, we ask about ANY history of alpha-1 blocker use, not just current use, because the effect persists. Second, we do not tell the patient to stop the drug preoperatively because stopping does not reliably prevent IFIS and can destabilise their BP or BPH. Third, we prepare intraoperatively with intracameral phenylephrine or iris hooks. With appropriate preparation, IFIS is a manageable challenge rather than a surgical emergency."

Yannick F. Bouchard-Tremblay, MD, FRCSC (Ophthalmology) — Cataract and Refractive Surgery Service, McGill University Health Centre, Montreal

🩺 A Practical Home BP Routine on Doxazosin

1. Seated BP using standard technique: seated 5 minutes, feet flat, arm at heart level, two readings
2. Standing BP at 1 minute and 3 minutes after standing up; note both the value and any symptoms
3. Twice daily: morning before medication and evening; more often when adjusting dose
4. Weekly log before office review; discard first day; average the rest
5. Flag any drop of 20 mmHg systolic or 10 mmHg diastolic or any symptomatic drop

Home BP Target Ranges

Why Standing BP Matters More Than Seated BP

On doxazosin, symptoms happen when standing. A patient with well-controlled seated BP and profoundly low standing BP (below 100/60 mmHg) is at real syncope and fall risk, even if their office reading looks reassuring. The home log capturing both positions gives the full clinical picture.

🤝 Why Combination Therapy Makes Mechanistic Sense

🔬 The MTOPS Trial Evidence

The Medical Therapy of Prostatic Symptoms (MTOPS) trial randomised BPH patients to doxazosin monotherapy, finasteride monotherapy, both drugs, or placebo. Combination therapy was significantly superior to either monotherapy for the primary outcome of BPH progression (acute urinary retention, need for surgery). This established combination therapy as a legitimate strategy for men with clinically significant BPH and enlarged prostates.

When Combination Therapy Is Considered

• Enlarged prostate (typically greater than 40 mL by ultrasound or DRE)
• Elevated PSA (typically greater than 1.5 ng/mL) — predicts progression
• Moderate to severe symptoms despite alpha-1 blocker monotherapy
• History of acute urinary retention or high risk of retention
• Patient preference for pharmacological rather than surgical management long-term

Note: 5-alpha reductase inhibitors have their own side effects (decreased libido, erectile dysfunction, gynecomastia) that should be discussed before starting combination therapy.

🚨 SEEK URGENT MEDICAL CARE FOR

• Syncope or near-syncope at any time
• Sustained penile erection lasting more than 4 hours (priapism) — section 19
• Chest pain or new shortness of breath — ALLHAT heart failure signal should be recognised
• Signs of severe hypotension — profound fatigue, confusion, cold extremities
• Sudden severe abdominal pain with fainting — rare vascular events

⚠️ Contact Prescriber Same or Next Day For

• Persistent dizziness on standing beyond the first 2 weeks
• Standing BP persistently below 100/60 mmHg with symptoms
• Any fall or near-fall
• New leg swelling
• New medication started elsewhere — PDE5 inhibitor, diuretic, another antihypertensive
• Planned cataract surgery — disclose alpha-1 blocker history (section 13)
• Palpitations that persist

Rare But Recognised Adverse Effects

Doxazosin can rarely be associated with priapism (section 19), leukopenia, thrombocytopenia, and hepatocellular injury. Any unexplained bruising, bleeding, infections, or abnormal LFT deserves review and consideration of drug attribution.

🩹 Common Doxazosin Side Effects with Expected Trajectory

Where Doxazosin's Profile Is Favourable

Neutral to favourable effect on lipids and glucose metabolism (section 18); no cough, no bronchospasm concerns; no interference with rate control; dual coverage of hypertension and BPH in the older male patient; effective in resistant hypertension as add-on. These are the specific settings where doxazosin genuinely earns its modern place despite the ALLHAT setback.

⚕️ Doxazosin Metabolic Profile

Comparative Metabolic Profiles

The Clinical Reality of the Favourable Metabolic Effect

The metabolic changes are real but small — they do not substitute for a statin, glucose-lowering therapy, or lifestyle change in patients who need those. The ALLHAT finding also demonstrated that favourable metabolic profile does not translate into improved cardiovascular outcomes if the drug carries other risks. Nonetheless, in a patient with dyslipidaemia or borderline glucose who requires an add-on antihypertensive, the metabolically neutral-to-favourable profile of doxazosin is a modest advantage.

🚩 PRIAPISM — SEEK EMERGENCY CARE FOR

• Erection lasting more than 4 hours, not related to sexual arousal
• Painful penile erection at any duration
• Erection that has not resolved after ejaculation or usual detumescence stimuli

Do not wait — ischaemic priapism produces permanent damage within 6-12 hours.

Frequency and Risk Factors

• Very rare — incidence is a fraction of one percent overall
• Higher risk with concurrent PDE5 inhibitor use
• Higher risk in sickle cell disease (background predisposition to priapism)
• Higher risk with concurrent intracavernosal injection therapy for ED
• Higher risk with certain psychiatric medications (trazodone, atypical antipsychotics)

Counselling at First Prescription

Every man prescribed doxazosin should be counselled about the priapism risk at first prescription and should be told to seek emergency care immediately for any prolonged erection. This conversation is often awkward but is important because delayed presentation is the main determinant of poor outcome. Written information in the dispensing pack reinforces the message.

⏰ What to Do About a Missed Dose

❌ Doubling Up Is Never Useful and Can Be Dangerous

A double dose of doxazosin produces amplified BP fall and can precipitate symptomatic hypotension, syncope, or falls. The long half-life means the extra effect persists for many hours. Skip and resume the usual schedule instead.

The 7-Day Reset Rule

After a 7-day or longer gap, receptor sensitivity resumes and the first-dose phenomenon returns. Restarting at the maintenance dose can produce syncope. The safe restart is 1 mg at bedtime, then titrate back over 1-2 weeks. This is important after hospitalisations, illness periods, or medication supply gaps.

🤰 Doxazosin in Pregnancy at a Glance

Practical Implications

A woman of childbearing potential started on doxazosin for hypertension should be counselled about contraception and, when planning pregnancy, switched to labetalol or another pregnancy-compatible alternative 2-3 months before conception. If pregnancy is confirmed on doxazosin, contact the prescriber for switch guidance.

🕰️ Elderly-Specific Doxazosin Considerations

The BPH-Only Elderly Patient Consideration

In an elderly man with BPH but no hypertension (or well-controlled hypertension on other agents), a uroselective alpha-1 blocker (tamsulosin, silodosin) produces the BPH benefit with less cardiovascular effect and lower falls risk than doxazosin. This switch is often the right move as patients age and become more fall-prone.

The Hepatic Clearance Advantage in CKD

Because doxazosin is largely hepatically cleared, the drug does not accumulate abruptly with declining renal function. This is a genuine advantage in the elderly BPH patient with concurrent CKD (a common combination) — doxazosin can be used with monitoring at standard doses in most CKD stages. Dialysis does not remove significant doxazosin, so post-dialysis supplementation is not needed.

✅ Good Combinations With Doxazosin

❌ Avoid or Extreme Caution

• Another alpha-1 blocker (terazosin, tamsulosin, prazosin) — no additional benefit, additive hypotension
• PDE5 inhibitors without dose caution — additive hypotension; use lowest PDE5 dose, separate by 4-6 hours
• Combination with heart failure risk — ALLHAT lesson; watch signs of heart failure development

Where Doxazosin Fits in Resistant Hypertension

Resistant hypertension is defined as BP above target on three antihypertensives (including a diuretic) at maximum doses. Standard fourth-line agent is spironolactone based on PATHWAY-2 evidence. Doxazosin is a legitimate fifth-line or resistant-HTN alternative when spironolactone is not tolerated or contraindicated.

🚫 ABSOLUTE CONTRAINDICATIONS

• Prior severe hypotensive syncope on this or another alpha-1 blocker
• Prior priapism on this or another alpha-1 blocker
• Symptomatic hypotension from any cause
• Documented doxazosin hypersensitivity

⚠️ RELATIVE CONTRAINDICATIONS AND SPECIFIC CAUTIONS

• Established heart failure — ALLHAT signal; alternative agents preferred
• Frail elderly with fall history — uroselective alpha-1 blocker for BPH-only alternative
• Severe hepatic impairment — hepatic clearance impaired
• Concurrent PDE5 inhibitor without spacing — additive hypotension
• Planned cataract surgery — not a contraindication but disclosure required (section 13)
• Pregnancy — alternatives preferred (section 21)
• Concurrent strong CYP3A4 inhibitors — enhanced hypotension risk
• Age under 18 — specialist decision

The Uroselective Switch Decision

When BPH is the sole target and the patient is normotensive (or has BP controlled on other agents), switching to a uroselective alpha-1 blocker (tamsulosin, silodosin) provides the BPH benefit with less BP effect, less postural hypotension, and lower falls risk. The trade-off is more retrograde ejaculation (specifically with silodosin). Discuss with the patient before the switch.

⌛ What Happens When Cardura Is Stopped

Legitimate Reasons to Stop Cardura

• Prior severe syncope on the drug
• Prior priapism
• Development of heart failure
• Persistent intolerable postural symptoms
• Falls with injury attributed to postural hypotension
• Switch to uroselective agent for BPH-only
• Pregnancy planning (women)
• End-of-life care where reducing pill burden is prioritised

Practical Approach to Stopping

For safety-driven cessation (syncope, priapism, heart failure), abrupt cessation is appropriate. For elective switching or deprescribing, a gradual dose reduction over 1-2 weeks is gentler. Replacement therapy (for BP or BPH) should be in place before or shortly after stopping doxazosin to avoid uncontrolled symptoms.

🌡️ Storage and Handling

• Room temperature 20-25 °C; short excursions 15-30 °C acceptable
• Dry environment — humidity can affect tablet integrity
• Original packaging preferred; transfer to organiser only for 7-14 days
• Out of direct sunlight
• Out of reach of children — doxazosin overdose in children can produce profound hypotension
• Check expiry date before use

🚩 NEVER CRUSH, SPLIT, OR CHEW CARDURA XL

Cardura XL uses an osmotic pump system that must remain intact. Crushing destroys the mechanism and delivers a full day's dose over 1-2 hours, producing severe hypotension and syncope.

The empty tablet shell may appear intact in the stool after use — this is expected and does not indicate the drug has failed to release. If IR flexibility is needed (swallowing difficulty, dose splitting), IR tablets can be split at the scored line.

The "Ghost Tablet" Phenomenon

Patients on Cardura XL sometimes notice what looks like an intact tablet in their stool. This is the empty osmotic shell after drug release — expected and harmless. Counselling about this at first prescription prevents alarm and non-adherence based on the assumption the drug is not being absorbed.

✈️ Travel Preparation Checklist

1. Carry trip supply plus 5-7 extra days — particularly important because a 7-day gap resets first-dose sensitivity
2. Split supply between carry-on and checked luggage
3. Keep tablets in original packaging for customs identification
4. Carry the prescription label for international travel
5. Note the generic name (doxazosin mesylate) in case a local pharmacy needs to identify the drug
6. Time zones: shift the daily dose by 1-2 hours per day of travel; do not skip more than 1 day

Gastroenteritis on Travel — Specific Hazard

On doxazosin, volume depletion from prolonged vomiting or diarrhoea amplifies the BP effect and can precipitate syncope. Practical response: hold a dose or two of doxazosin during acute severe gastroenteritis, rehydrate orally aggressively, resume when the illness settles. If the illness lasts more than 7 days, the first-dose sensitivity may reset — restart at 1 mg bedtime and titrate up.

Long-Haul Flights and Doxazosin

Long flights combine dehydration and immobility with the ongoing alpha-1 blocker effect. Practical measures: extra hydration, aisle-side seat for regular walking, avoid excess alcohol (adds to vasodilation), consider compression stockings on flights over 8 hours. On arrival, allow time to acclimatise before physical activity.

💬 A Useful Annual-Review Conversation on Cardura

1. Home BP readings for the past week: seated AND standing averages
2. Symptomatic review: dizziness on standing? Falls? Near-falls?
3. BPH indication (if applicable): is the drug still helping symptoms? IPSS score if formal
4. HTN indication (if applicable): is doxazosin still needed given other agents?
5. Cataract surgery history/plans: any recent or upcoming eye surgery?
6. Sexual health: any priapism warning? PDE5 inhibitor use pattern?
7. Interacting medications: any new drugs from other prescribers?
8. Life changes: recurrent falls, new heart failure diagnosis, planned pregnancy
9. Uroselective switch consideration: for BPH-only elderly patients

❓ Three Questions Worth Asking Your Prescriber

1. Is doxazosin still the right drug for me? If ALLHAT applies to your case, consider first-line alternatives.
2. Would a uroselective alpha-1 blocker suit me better? If BPH is the sole target and falls are a concern.
3. What are the warning signs I should watch for? Falls, priapism, cataract surgery disclosure, PDE5 inhibitor caution.

A Closing Note

"Cardura is a drug whose role has narrowed rather than expanded since introduction — a genuinely unusual medication story. ALLHAT taught us to be careful about assuming favourable metabolic profile translates into cardiovascular benefit. But doxazosin has not disappeared: it retains legitimate first-line status for symptomatic BPH, dual benefit in the older man with both BPH and hypertension, and add-on value in resistant hypertension. When prescribed with attention to the bedtime first-dose rule, home BP monitoring including standing readings, and disclosure to any cataract surgeon, doxazosin remains a useful tool in the modern cardiovascular formulary."

Bronte-Alina H. Ferreira-Batista, MD, PhD — Family Medicine, Universidade de Sao Paulo Faculdade de Medicina